Viking Therapeutics, Inc.

VKTX

$28.33

Name : Viking Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $3,612,257,280.00

EPSttm : -5.42

Viking Therapeutics, Inc.

$28.33

0.40%

$0.114

VKTX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

19.52

Margin Of Safety %

Put/Call OI Ratio

0.22

EPS Next Q Diff

0.19

EPS Last/This Y

-2.12

EPS This/Next Y

0.11

Price

28.43

Target Price

95.32

Analyst Recom

1.19

Performance Q

-13.66

Upside

-347.3%

Beta

0.75

Ticker: VKTX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	VKTX	26.67	0.23	0.28	332742
2026-10-14	VKTX	25.55	0.23	0.15	340917
2026-10-15	VKTX	27.39	0.23	0.78	348645
2026-10-16	VKTX	25.17	0.22	0.59	354298
2026-10-19	VKTX	25.06	0.20	0.32	267087
2026-10-20	VKTX	26.74	0.20	0.10	272700
2026-10-21	VKTX	26.4	0.20	0.29	282117
2026-10-22	VKTX	25.82	0.20	1.40	287763
2026-10-23	VKTX	24.39	0.22	0.41	295975
2026-10-26	VKTX	24.24	0.22	0.15	289833
2026-10-27	VKTX	24.89	0.22	0.31	294934
2026-10-28	VKTX	25.36	0.22	0.38	298343
2026-10-29	VKTX	26.89	0.22	0.10	306276
2026-10-30	VKTX	27.31	0.22	0.28	309827
2026-11-02	VKTX	26.83	0.21	0.35	289357
2026-11-03	VKTX	26.09	0.21	0.32	292702
2026-11-04	VKTX	27.97	0.21	0.09	295650
2026-11-05	VKTX	25.78	0.21	0.51	300237
2026-11-06	VKTX	26.86	0.21	0.54	301123
2026-11-09	VKTX	28.99	0.22	0.16	292555
2026-11-10	VKTX	28.66	0.22	0.14	296696
2026-11-11	VKTX	28.34	0.22	0.49	300345
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	VKTX	26.66	-31.5	-	-4.60
2026-10-14	VKTX	25.48	-31.5	-	-4.60
2026-10-15	VKTX	27.40	-31.5	-	-4.60
2026-10-16	VKTX	25.17	-31.0	-	-4.59
2026-10-19	VKTX	25.05	-31.0	-	-4.59
2026-10-20	VKTX	25.05	-31.0	-	-4.59
2026-10-21	VKTX	26.72	-31.0	-	-4.59
2026-10-22	VKTX	25.83	-31.0	-	-4.59
2026-10-23	VKTX	24.39	-31.0	-	-4.59
2026-10-26	VKTX	24.24	-30.9	-	-4.59
2026-10-27	VKTX	24.88	-30.9	-	-4.59
2026-10-28	VKTX	25.38	-30.9	-	-4.59
2026-10-29	VKTX	26.91	-30.9	-	-4.59
2026-10-30	VKTX	27.31	-30.9	-	-4.59
2026-11-02	VKTX	26.83	2.4	-	-5.31
2026-11-03	VKTX	26.11	2.4	-	-5.31
2026-11-04	VKTX	28.00	2.4	-	-5.31
2026-11-05	VKTX	25.77	2.4	-	-5.31
2026-11-06	VKTX	26.86	2.4	-	-5.31
2026-11-09	VKTX	28.98	2.4	-	-5.31
2026-11-10	VKTX	28.67	2.4	-	-5.31
2026-11-11	VKTX	28.43	2.0	-	-5.31
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	VKTX	-4.43	2.09	21.06
2026-10-14	VKTX	-4.43	2.09	21.06
2026-10-15	VKTX	-4.43	2.09	21.06
2026-10-16	VKTX	-4.43	2.09	21.06
2026-10-19	VKTX	-4.80	2.00	21.00
2026-10-20	VKTX	-4.80	2.00	21.00
2026-10-21	VKTX	-4.80	2.00	21.00
2026-10-22	VKTX	-4.80	2.00	21.00
2026-10-23	VKTX	-4.80	2.00	21.00
2026-10-26	VKTX	-4.80	1.95	21.00
2026-10-27	VKTX	-4.80	1.95	20.69
2026-10-28	VKTX	-4.80	1.95	20.69
2026-10-29	VKTX	-4.80	1.95	20.69
2026-10-30	VKTX	-4.80	1.95	20.69
2026-11-02	VKTX	-4.79	1.88	20.63
2026-11-03	VKTX	-4.79	1.88	20.63
2026-11-05	VKTX	-4.79	1.88	20.63
2026-11-06	VKTX	-4.79	1.88	20.63
2026-11-09	VKTX	-4.79	1.81	20.63
2026-11-10	VKTX	-4.79	1.81	20.63
2026-11-11	VKTX	-4.79	1.81	19.52
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.55

Avg. EPS Est. Current Quarter

-1.35

Avg. EPS Est. Next Quarter

-1.36

Insider Transactions

-4.79

Institutional Transactions

1.81

Beta

0.75

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

71.4

Max Drawdown 5-Year %

-78.9

Target Price

95.32

P/E

Forward P/E

PEG

P/S

P/B

6.16

P/Free Cash Flow

EPS

-5.41

Average EPS Est. Cur. Y

-5.31

EPS Next Y. (Est.)

-5.21

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.53

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

-0.7

EPS 1 30Days Diff

-0.71

EBIT Estimation

◆ VKTX Healthcare

$28.44

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

13/25

Volume

8/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

52.6

Range 1M

77.2%

Sup Dist

1.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

5/30

Estimates

0/20

Inst/Vol

3/15

Options

8/10

EPS Yr

-64.7%

EPS NY

4.2%

52W%

25.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +235.2% upside

Quality

2/30

Valuation

15/30

Growth

1/25

Stability

7/10

LT Trend

1/5

Upside

+235.2%

Quality

VKTX — P/E HistoricalBiotechnology

Viking Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 74

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

VKTX

Latest News

—

Caricamento notizie per VKTX…

stock quote shares VKTX – Viking Therapeutics Inc. Stock Price stock today

news today VKTX – Viking Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VKTX – Viking Therapeutics Inc. yahoo finance google finance

stock history VKTX – Viking Therapeutics Inc. invest stock market

stock prices VKTX premarket after hours

ticker VKTX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VKTX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y